Brigatinib

CAS No.

1197953-54-0

MDL No.

MFCD29472221

C₂₉H₃₉ClN₇O₂P

584.10

InChI Key

AILRADAXUVEEIR-UHFFFAOYSA-N

Pack Size	Purity	Price	Availability	Action
-	-	On Request	On Request
Custom synthesis and bulk supply options are available upon request.

Pack Size

Purity

Price

Availability

Action

On Request

Custom synthesis and bulk supply options are available upon request.

Product Information

Brigatinib is an organic molecule with antineoplastic activity as a tyrosine kinase inhibitor.

CAS No.	1197953-54-0
Product Name	Brigatinib

Biological Targets

ALK·EGFR

Associated Conditions

lung cancer·non-small cell lung carcinoma·neoplasm·anaplastic large cell lymphoma·carcinoma

* The information provided here is compiled from public sources and is for reference only.

Pricing & Availability

Product Information

Biological Profile

Safety Information

Properties

Biological Targets

Associated Conditions

Documentation

Brigatinib

Pricing & Availability

Product Information

Biological Profile

Safety Information

Properties

Biological Targets

Associated Conditions

Related Articles

EML4-ALK Variants: Biological and Molecular Properties, and the Implications for Patients.

The activity, safety, and evolving role of brigatinib in patients with -rearranged non-small cell lung cancers.

Brigatinib: First Global Approval.

A crowded, but still varied, space: brigatinib in anaplastic lymphoma kinase-rearranged non-small cell lung cancer.

Documentation

Similar Products

5-Chloro-N2-(4-(4-(dimethylamino)-1-piperidinyl)-2-methoxyphenyl)-N4-(2-(dimethylphosphinyl)phenyl)-2,4-pyrimidinediamine

Iruplinalkib